Quality-Adjusted Life-Years Lost Due to COVID-19 Mortality: Methods and Application for The Netherlands-Reference-Cited by-同舟云学术

Quality-Adjusted Life-Years Lost Due to COVID-19 Mortality: Methods and Application for The Netherlands

Published:2022-05 Issue:5 Volume:25 Page:731-735
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Wouterse Bram,Ram Frederique,van Baal Pieter

Funder

Network for Studies on Pensions, Aging and Retirement

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference22 articles.

1. Estimating (quality-adjusted) life-year losses associated with deaths: with application to COVID-19;Briggs;Health Econ,2020

2. Quality-adjusted life-year losses averted with every COVID-19 infection prevented in the United States;Basu;Value Health,2021

3. Use of “normal” risk to improve understanding and dangers of COVID-19;Spiegelhalter;BMJ,2020

4. Prediction models for diagnosis and prognosis of Covid-19: systematic review and critical appraisal [published correction appears in BMJ. 2020;369:m2204];Wynants;BMJ,2020

5. Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform;Bhaskaran;Lancet Reg Health Eur,2021

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Societal costs of sepsis in the Netherlands;Critical Care;2024-01-22

2. Quantifying income inequality in years of life lost to COVID-19: a prediction model approach using Dutch administrative data;International Journal of Epidemiology;2023-12-11

3. Health and Economic Impacts of Lockdown Policies in the Early Stage of COVID-19 in the United States;Service Science;2023-09

4. Economic Evaluation of Wastewater Surveillance Combined with Clinical COVID-19 Screening Tests, Japan;Emerging Infectious Diseases;2023-08

5. Health Outcomes and Cost-effectiveness of Monoclonal SARS-CoV-2 Antibodies as Pre-exposure Prophylaxis;JAMA Network Open;2023-07-06